Altamira Therapeutics Announces Expansion of Bentrio License and Distribution Agreement with Nuance Pharma in East and South East Asia
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 16 2024
0mins
Source: Newsfilter
Nuance Pharma Expansion: Nuance Pharma has launched its Bentrio® nasal spray in Hong Kong and is seeking marketing authorization for Mainland China, while extending its exclusive license agreement to include seven additional countries in East and South East Asia, covering a population of over 630 million.
Product Efficacy: Bentrio is a drug-free nasal spray designed to protect against airborne allergens and viruses, showing significant efficacy in clinical trials for allergic rhinitis, with improvements in symptom scores and quality of life for users.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
